Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Shares Outstanding: 2020-2023

Historic Shares Outstanding for Cullinan Therapeutics (CGEM) over the last 4 years, with Sep 2023 value amounting to $42.8 million.

  • Cullinan Therapeutics' Shares Outstanding fell 6.52% to $42.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was $42.8 million, marking a year-over-year decrease of 6.52%. This contributed to the annual value of $45.8 million for FY2022, which is 3.40% up from last year.
  • As of Q3 2023, Cullinan Therapeutics' Shares Outstanding stood at $42.8 million, which was up 0.06% from $42.7 million recorded in Q2 2023.
  • Cullinan Therapeutics' 5-year Shares Outstanding high stood at $45.8 million for Q4 2022, and its period low was $20.0 million during Q1 2020.
  • Moreover, its 3-year median value for Shares Outstanding was $43.7 million (2021), whereas its average is $43.8 million.
  • As far as peak fluctuations go, Cullinan Therapeutics' Shares Outstanding surged by 117.91% in 2021, and later declined by 11.90% in 2023.
  • Over the past 4 years, Cullinan Therapeutics' Shares Outstanding (Quarterly) stood at $29.8 million in 2020, then soared by 48.48% to $44.3 million in 2021, then rose by 3.40% to $45.8 million in 2022, then declined by 6.52% to $42.8 million in 2023.
  • Its Shares Outstanding was $42.8 million in Q3 2023, compared to $42.7 million in Q2 2023 and $39.3 million in Q1 2023.